Trulieve Cannabis Non-GAAP EPS of $0.11 beats by $0.08, revenue of $271M beats by $2.12MAugust 7, 2026
Share Facebook Twitter LinkedIn Pinterest Email T2 Biosystems spikes as FDA clearance for T2Bacteria Panel expands
Trulieve Cannabis Non-GAAP EPS of $0.11 beats by $0.08, revenue of $271M beats by $2.12MAugust 7, 2026
Nature’s Sunshine targets $1B in sales and 15% EBITDA margin while cutting 2026 sales outlook to $490M-$500M (NASDAQ:NATR)August 7, 2026
